Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
Authors
Keywords
-
Journal
JOURNAL OF HEADACHE AND PAIN
Volume 19, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-26
DOI
10.1186/s10194-018-0921-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Botulinum toxin: A review of the mode of action in migraine
- (2018) T. P. Do et al. ACTA NEUROLOGICA SCANDINAVICA
- OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine
- (2018) James E. Frampton et al. DRUGS
- Prospective real-world analysis of OnabotulinumtoxinA in chronic migraine post-National Institute for Health and Care Excellence UK technology appraisal
- (2018) A. P. Andreou et al. EUROPEAN JOURNAL OF NEUROLOGY
- Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
- (2018) Andrew M. Blumenfeld et al. JOURNAL OF HEADACHE AND PAIN
- An academic debate: OnabotulinumtoxinA for chronic migraine: PREEMPT-derived vs “customized” dosing/injection paradigm
- (2018) Mark W. Green et al. TOXICON
- Botulinum toxin for chronic migraine: Clinical trials and technical aspects
- (2018) Cristina Tassorelli et al. TOXICON
- OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study
- (2017) C. Domínguez et al. EUROPEAN JOURNAL OF NEUROLOGY
- CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study
- (2017) Clara Domínguez et al. HEADACHE
- The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis
- (2017) Manjit Matharu et al. JOURNAL OF HEADACHE AND PAIN
- Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centers
- (2017) Cristina Tassorelli et al. JOURNAL OF HEADACHE AND PAIN
- OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study
- (2017) Elif Ilgaz Aydinlar et al. JOURNAL OF HEADACHE AND PAIN
- Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design
- (2017) Daniel Serrano et al. JOURNAL OF HEADACHE AND PAIN
- Stopping Onabotulinum Treatment after the First Two Cycles Might Not Be Justified: Results of a Real-life Monocentric Prospective Study in Chronic Migraine
- (2017) Paola Sarchielli et al. Frontiers in Neurology
- The added value of an electronic monitoring and alerting system in the management of medication-overuse headache: A controlled multicentre study
- (2016) Cristina Tassorelli et al. CEPHALALGIA
- OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program
- (2016) Richard B Lipton et al. CEPHALALGIA
- Onabotulinumtoxin-A treatment in Greek patients with chronic migraine
- (2016) Michail Vikelis et al. JOURNAL OF HEADACHE AND PAIN
- Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting
- (2016) Katja Kollewe et al. JOURNAL OF NEURAL TRANSMISSION
- Migraine and its psychiatric comorbidities
- (2016) Mia Tova Minen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Factors associated with favorable outcome in botulinum toxin A treatment for chronic migraine: A clinic-based prospective study
- (2016) Mi Ji Lee et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine
- (2016) Bekir Enes Demiryurek et al. NEUROLOGICAL SCIENCES
- Refractory chronic migraine: is drug withdrawal necessary before starting a therapy with onabotulinum toxin type A?
- (2016) Calogera Butera et al. NEUROLOGICAL SCIENCES
- The use of onabotulinum toxin A (Botox®) in the treatment of chronic migraine at the Parma Headache Centre: a prospective observational study
- (2016) Marco Russo et al. NEUROLOGICAL SCIENCES
- Treatment of medication-overuse headache: A systematic review
- (2015) Chia-Chun Chiang et al. CEPHALALGIA
- A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience
- (2015) Andrea Negro et al. JOURNAL OF HEADACHE AND PAIN
- Assessing Clinically Meaningful Treatment Effects in Controlled Trials: Chronic Migraine as an Example
- (2015) David W. Dodick et al. JOURNAL OF PAIN
- Does analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuse
- (2015) Fayyaz Ahmed et al. SpringerPlus
- OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study
- (2015) Andrea Negro et al. SpringerPlus
- OnabotulinumtoxinA treatment for chronic migraine: experience in 52 patients treated with the PREEMPT paradigm
- (2015) María Isabel Pedraza et al. SpringerPlus
- Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine
- (2014) H.-C. Diener et al. EUROPEAN JOURNAL OF NEUROLOGY
- Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine
- (2014) John F. Rothrock et al. HEADACHE
- Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK
- (2014) Modar Khalil et al. JOURNAL OF HEADACHE AND PAIN
- Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT
- (2014) Stephen D Silberstein et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Botulinum toxin A: a new option for treatment of chronic migraine with medication overuse
- (2014) Licia Grazzi et al. NEUROLOGICAL SCIENCES
- The cost effectiveness of Botox in Italian patients with chronic migraine
- (2014) M. Ruggeri NEUROLOGICAL SCIENCES
- OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program
- (2013) S. K. Aurora et al. ACTA NEUROLOGICA SCANDINAVICA
- Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2012
- (2013) M. A. Leone et al. EUROPEAN JOURNAL OF NEUROLOGY
- OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline
- (2013) Stephen D. Silberstein et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK
- (2013) Anthony J. Batty et al. JOURNAL OF MEDICAL ECONOMICS
- Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: A comparison of two consecutive treatment methods in an open-label design
- (2012) Signe B Munksgaard et al. CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
- (2010) SK Aurora et al. CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
- (2010) HC Diener et al. CEPHALALGIA
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
- (2010) David W. Dodick et al. HEADACHE
- A Multi-Center Double-Blind Pilot Comparison of OnabotulinumtoxinA and Topiramate for the Prophylactic Treatment of Chronic Migraine
- (2010) Roger K. Cady et al. HEADACHE
- Global prevalence of chronic migraine: A systematic review
- (2009) JL Natoli et al. CEPHALALGIA
- A Double-Blind Comparison of OnabotulinumtoxinA (BOTOX®) and Topiramate (TOPAMAX®) for the Prophylactic Treatment of Chronic Migraine: A Pilot Study
- (2009) Ninan T. Mathew et al. HEADACHE
- Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin
- (2008) Parisa Gazerani et al. PAIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search